Amylase
Amylase is a group of glycoside hydrolase enzymes that catalyze the digestion of starch and glycogen by cleaving internal α-1,4-glycosidic bonds.
Amylase is a group of glycoside hydrolase enzymes that catalyze the digestion of starch and glycogen by cleaving internal α-1,4-glycosidic bonds. The principal human forms are salivary α-amylase, produced mainly by the salivary glands, and pancreatic α-amylase, secreted into the small intestine. Their activity converts complex carbohydrates into shorter dextrins, maltose, maltotriose, and other oligosaccharides that are subsequently processed into absorbable sugars such as glucose.
Amylase is important in carbohydrate metabolism and is commonly studied in relation to postprandial blood glucose and diabetes. Inhibition of α-amylase can slow starch breakdown and may reduce the rate at which glucose becomes available for absorption; for this reason, α-amylase is frequently evaluated together with acid α-glucosidase (AAG), which catalyzes a later step in carbohydrate digestion. Amylase is also a clinical laboratory enzyme, although interpretation of circulating amylase activity depends on the clinical setting and is distinct from the use of α-amylase as a pharmacological or nutritional target.
Where the papers sit
10 papers from the last 6 months study amylase directly · updated from PubMed 4 Nov 2026
Study type 0 clinical trials · 3 human data · 7 preclinical
Themes 3 themes · 1 new direction
-
Dual Enzyme Inhibitors in Diabetes
Synthetic dual inhibitors of α-amylase and α-glucosidase are being developed as alternatives to acarbose for type 2 diabetes. Bis-oxadiazoles, thiazolidinone-thiazoles, benzothiazole conjugates and thiazolidinediones recur across structure-activity, docking and DFT analyses. Reported priorities are improved inhibitory potency, multitarget activity and drug-like ADME properties. Most evidence remains computational or enzymatic, leaving cellular and clinical efficacy unresolved.
5 papers · 50%
-
Amylase Inhibition and Detection
Amylase and glucosidase research here combines rapid enzyme detection with phytochemical inhibition of carbohydrate digestion. Interfacial nanozymes are being developed for sensitive amylase quantification, while polysaccharides and plant-derived compounds are tested against α-amylase and α-glucosidase. The biological rationale is improved glucose tolerance and reduced hyperglycemia, supported by biochemical assays and computational binding studies. Evidence remains preclinical, with no clear consensus on which inhibitor class is most effective.
4 papers · 40%
-
Glycosidase Targeting in Breast Cancer
Targeted inhibition of α- and β-glucosidase and amylase is being explored as a way to induce metabolic dysfunction in breast cancer cells. The evidence centers on carbohydrate-enzyme inhibition and cell-viability assays rather than clinical outcomes. Acarbose and aminoglycoside or aminocyclitol compounds frame the pharmacological comparisons. Whether this metabolic vulnerability produces selective antitumour activity remains open.
1 papers · 10%
Amylase becomes a manufacturing analyte rather than a therapeutic enzyme target
The Au@MOF-235 self-cascading nanozyme for food-manufacturing amylase detection treats amylase as an activity to be quantified, rather than as a carbohydrate-hydrolyzing enzyme to inhibit for diabetes or cancer-related applications. The platform detects α-, β-, γ-amylase, and pullulanase across useful activity ranges with low detection limits, shifting amylase research toward process monitoring and analytical quality control in complex manufacturing environments 42900251Oct.
Papers
The 10 papers from the last 6 months that study amylase directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Dual Enzyme Inhibitors in Diabetes (5)
- Computer-aided development of novel thiazolidinone-thiazole derivatives: multidimensional structure-activity relationships revealed by quantum chemical analysis, molecular docking and biological investigation. Journal of computer-aided molecular design · 16 Oct 2026 PMID 42886389
- Design, synthesis, and computational assessment of bis-oxadiazole ligands targeting α-amylase and α-glucosidase: DFT, docking, and ADME studies. Future medicinal chemistry · 18 Sept 2026 PMID 42755370
- Design, synthesis and biological evaluation of hydroxybenzothiazole-linked benzothiazole/benzoxazole conjugates as potent dual α-amylase and α-glucosidase inhibitors. Bioorganic chemistry · 30 Aug 2026 PMID 42669271
- 2,4-thiazolidinediones as dual-target inhibitors against carbohydrate metabolism enzymes in type 2 diabetes. Bioorganic chemistry · 12 Jun 2026 PMID 42284877
- β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
Amylase Inhibition and Detection (4)
- Interfacial engineering-tailored self-cascading nanozyme for sensitive and rapid detection of different amylases. Mikrochimica acta · 20 Oct 2026 PMID 42900251
- In silico inhibition mechanism of α-amylase and α-glucosidase by fragransinic acid and bellericagenin B, two compounds from Combretum fragrans F. Hoffm (Combretaceae). Zeitschrift fur Naturforschung. C, Journal of biosciences · 4 Sept 2026 PMID 42696156
- Nyctanthes arbor-tristis attenuates hyperglycemia: an integrated experimental and computational investigation. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 27 Aug 2026 PMID 42658420
- Structural elucidation and α-amylase/α-glucosidase inhibition properties of xyloglucan and RG-I types polysaccharides from tamarind (Tamarindus indica L.) pulp. Carbohydrate polymers · 23 Jul 2026 PMID 42493157
Glycosidase Targeting in Breast Cancer (1)
- Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction. ChemMedChem · 15 Aug 2026 PMID 42603779
By study type
Human data, design not indexed (3)
- Computer-aided development of novel thiazolidinone-thiazole derivatives: multidimensional structure-activity relationships revealed by quantum chemical analysis, molecular docking and biological investigation. Journal of computer-aided molecular design · 16 Oct 2026 PMID 42886389
- Design, synthesis, and computational assessment of bis-oxadiazole ligands targeting α-amylase and α-glucosidase: DFT, docking, and ADME studies. Future medicinal chemistry · 18 Sept 2026 PMID 42755370
- β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
Preclinical: animal, cell and lab studies (7)
- Interfacial engineering-tailored self-cascading nanozyme for sensitive and rapid detection of different amylases. Mikrochimica acta · 20 Oct 2026 PMID 42900251
- In silico inhibition mechanism of α-amylase and α-glucosidase by fragransinic acid and bellericagenin B, two compounds from Combretum fragrans F. Hoffm (Combretaceae). Zeitschrift fur Naturforschung. C, Journal of biosciences · 4 Sept 2026 PMID 42696156
- Design, synthesis and biological evaluation of hydroxybenzothiazole-linked benzothiazole/benzoxazole conjugates as potent dual α-amylase and α-glucosidase inhibitors. Bioorganic chemistry · 30 Aug 2026 PMID 42669271
- Nyctanthes arbor-tristis attenuates hyperglycemia: an integrated experimental and computational investigation. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 27 Aug 2026 PMID 42658420
- Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction. ChemMedChem · 15 Aug 2026 PMID 42603779
- Structural elucidation and α-amylase/α-glucosidase inhibition properties of xyloglucan and RG-I types polysaccharides from tamarind (Tamarindus indica L.) pulp. Carbohydrate polymers · 23 Jul 2026 PMID 42493157
- 2,4-thiazolidinediones as dual-target inhibitors against carbohydrate metabolism enzymes in type 2 diabetes. Bioorganic chemistry · 12 Jun 2026 PMID 42284877
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-08-20. Drafted by language models from published abstracts; not medical advice.